应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
CLRB Cellectar Biosciences Inc.
盘前交易 07-10 06:49:12 EDT
4.85
+0.15
+3.19%
最高
4.99
最低
4.70
成交量
11.95万
今开
4.70
昨收
4.70
日振幅
6.17%
总市值
1,386万
流通市值
1,361万
总股本
285.70万
成交额
57.98万
换手率
4.26%
流通股本
280.59万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
Cellectar Biosciences, Inc.盘中异动 股价大涨8.56%
市场透视 · 07-03
Cellectar Biosciences, Inc.盘中异动 股价大涨8.56%
Cellectar Biosciences, Inc.7月1日成交额为421.45万美元
市场透视 · 07-02
Cellectar Biosciences, Inc.7月1日成交额为421.45万美元
Cellectar Biosciences, Inc.盘中异动 急速下跌5.06%
市场透视 · 06-30
Cellectar Biosciences, Inc.盘中异动 急速下跌5.06%
Cellectar Biosciences, Inc.6月27日成交额为92.11万美元
市场透视 · 06-28
Cellectar Biosciences, Inc.6月27日成交额为92.11万美元
Cellectar Biosciences, Inc.6月25日成交额为230.98万美元
市场透视 · 06-26
Cellectar Biosciences, Inc.6月25日成交额为230.98万美元
Cellectar Biosciences, Inc.6月24日成交额为161.80万美元
市场透视 · 06-25
Cellectar Biosciences, Inc.6月24日成交额为161.80万美元
Cellectar Biosciences, Inc.6月23日成交额为67.12万美元
市场透视 · 06-24
Cellectar Biosciences, Inc.6月23日成交额为67.12万美元
Cellectar Biosciences, Inc.盘中异动 早盘股价大跌8.89%报0.333美元
市场透视 · 06-20
Cellectar Biosciences, Inc.盘中异动 早盘股价大跌8.89%报0.333美元
Cellectar Biosciences, Inc.6月17日成交额为88.25万美元
市场透视 · 06-18
Cellectar Biosciences, Inc.6月17日成交额为88.25万美元
Cellectar Biosciences, Inc.6月16日成交额为76.47万美元
市场透视 · 06-17
Cellectar Biosciences, Inc.6月16日成交额为76.47万美元
Cellectar Biosciences, Inc.盘中异动 早盘快速下挫5.01%
市场透视 · 06-13
Cellectar Biosciences, Inc.盘中异动 早盘快速下挫5.01%
Cellectar Biosciences, Inc.6月11日成交额为611.73万美元
市场透视 · 06-12
Cellectar Biosciences, Inc.6月11日成交额为611.73万美元
Cellectar Biosciences, Inc.盘中异动 早盘股价大涨5.18%报0.373美元
市场透视 · 06-10
Cellectar Biosciences, Inc.盘中异动 早盘股价大涨5.18%报0.373美元
Cellectar Biosciences, Inc.盘中异动 早盘大幅下跌5.18%报0.342美元
市场透视 · 06-09
Cellectar Biosciences, Inc.盘中异动 早盘大幅下跌5.18%报0.342美元
Cellectar Biosciences, Inc.6月6日成交额为334.48万美元
市场透视 · 06-07
Cellectar Biosciences, Inc.6月6日成交额为334.48万美元
Cellectar Biosciences, Inc.6月5日成交额为1606.51万美元
市场透视 · 06-06
Cellectar Biosciences, Inc.6月5日成交额为1606.51万美元
Cellectar Biosciences, Inc.6月4日成交额为3.38亿美元
市场透视 · 06-05
Cellectar Biosciences, Inc.6月4日成交额为3.38亿美元
Cellectar Biosciences, Inc.盘中异动 股价大涨5.65%报0.277美元
市场透视 · 06-03
Cellectar Biosciences, Inc.盘中异动 股价大涨5.65%报0.277美元
Cellectar Biosciences, Inc.盘中异动 股价大跌6.02%报0.248美元
市场透视 · 05-30
Cellectar Biosciences, Inc.盘中异动 股价大跌6.02%报0.248美元
Cellectar Biosciences, Inc.盘中异动 股价大跌5.11%报0.251美元
市场透视 · 05-21
Cellectar Biosciences, Inc.盘中异动 股价大跌5.11%报0.251美元
加载更多
公司概况
公司名称:
Cellectar Biosciences Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
Cellectar Biosciences, Inc.以前名为Novelos Therapeutics, Inc.于1996年6月成立于特拉华州。2014年2月11日,公司更名为现在的名字。该公司是一家后期临床生物制药公司,专注于癌症治疗药物的发现、开发和商业化。该公司的核心目标是利用专有的磷脂醚药物偶联物递送平台开发PDC,这些PDC旨在专门针对癌细胞,并由于更少的脱靶效应而提供更好的功效和更好的安全性。
发行价格:
--
{"stockData":{"symbol":"CLRB","market":"US","secType":"STK","nameCN":"Cellectar Biosciences Inc.","latestPrice":4.85,"timestamp":1752091200000,"preClose":4.7,"halted":0,"volume":119478,"delay":0,"floatShares":2805899,"shares":2857000,"eps":-23.39907,"marketStatus":"盘前交易","change":0.15,"latestTime":"07-10 06:49:12 EDT","open":4.7,"high":4.99,"low":4.7,"amount":579787.30626,"amplitude":0.061702,"askPrice":5.42,"askSize":100,"bidPrice":4.8,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-23.39907,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1752154200000},"marketStatusCode":1,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":4.85,"postHourTrading":{"tag":"盘后","latestPrice":4.94,"preClose":4.85,"latestTime":"19:59 EDT","volume":5672,"amount":27583.3957,"timestamp":1752105599821},"volumeRatio":0.3814384479719675,"impliedVol":1.1856,"impliedVolPercentile":0.937},"requestUrl":"/m/hq/s/CLRB","defaultTab":"news","newsList":[{"id":"2548209807","title":"Cellectar Biosciences, Inc.盘中异动 股价大涨8.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2548209807","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548209807?lang=zh_cn&edition=full","pubTime":"2025-07-03 21:31","pubTimestamp":1751549479,"startTime":"0","endTime":"0","summary":"北京时间2025年07月03日21时31分,Cellectar Biosciences, Inc.股票出现波动,股价大幅上涨8.56%。Cellectar Biosciences, Inc.股票所在的生物技术行业中,整体涨幅为0.10%。其相关个股中,Lixte Biotechnology Holdings, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Lixte Biotechnology Holdings Inc C/Wts 30/11/2025 涨幅较大,Windtree Therapeutics, Inc.、Clearmind Medicine Inc.、Lixte Biotechnology Holdings, Inc.较为活跃,换手率分别为1674.50%、513.57%、424.46%,振幅较大的相关个股有Lixte Biotechnology Holdings Inc C/Wts 30/11/2025 、Lixte Biotechnology Holdings, Inc.、Clearmind Medicine Inc.,振幅分别为27.18%、26.23%、12.17%。Cellectar Biosciences, Inc.公司简介:Cellectar Biosciences Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250703213119a4cd7c01&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250703213119a4cd7c01&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LIXT","BK4139","CLRB"],"gpt_icon":0},{"id":"2548832075","title":"Cellectar Biosciences, Inc.7月1日成交额为421.45万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548832075","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548832075?lang=zh_cn&edition=full","pubTime":"2025-07-02 09:33","pubTimestamp":1751420008,"startTime":"0","endTime":"0","summary":"美东时间2025年7月1日,Cellectar Biosciences, Inc.成交额为421.45万美元,成交额较昨日增加322.99%,当日成交量为86.09万股。Cellectar Biosciences, Inc.于2025年7月1日跌31.65%,报4.86美元,该股过去5个交易日跌49.9%,年初至今跌45.82%,过去60日跌44.71%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-07-01|421.45万|322.99%|86.09万|#|2025-06-30|99.64万|8.17%|12.95万|#|2025-06-27|92.11万|-61.20%|11.86万|#|2025-06-26|237.40万|2.78%|33.12万|#|2025-06-25|230.98万|42.75%|27.63万|Cellectar Biosciences Inc 是一家临床阶段的生物制药公司。公司有一个运营和可报告的部门,专注利用PDC平台开发治疗癌症的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702093658a72968fb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702093658a72968fb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CLRB"],"gpt_icon":0},{"id":"2548101442","title":"Cellectar Biosciences, Inc.盘中异动 急速下跌5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2548101442","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548101442?lang=zh_cn&edition=full","pubTime":"2025-07-01 02:09","pubTimestamp":1751306966,"startTime":"0","endTime":"0","summary":"北京时间2025年07月01日02时09分,Cellectar Biosciences, Inc.股票出现异动,股价大幅下挫5.06%。Cellectar Biosciences, Inc.股票所在的生物技术行业中,整体涨幅为0.13%。其相关个股中,Immatics N V C/Wts 01/07/2025 、Artelo Biosciences, Inc.、Klotho Neurosciences, Inc.涨幅较大,Artelo Biosciences, Inc.、Klotho Neurosciences, Inc.、Inmune Bio Inc.较为活跃,换手率分别为4706.92%、347.00%、121.86%,振幅较大的相关个股有Artelo Biosciences, Inc.、Immatics N V C/Wts 01/07/2025 、Seastar Medical Holding Corp C/Wts 28/10/2027 ,振幅分别为181.59%、130.77%、66.24%。Cellectar Biosciences, Inc.公司简介:Cellectar Biosciences Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250701020926a726a042&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250701020926a726a042&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CLRB"],"gpt_icon":0},{"id":"2546789647","title":"Cellectar Biosciences, Inc.6月27日成交额为92.11万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2546789647","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546789647?lang=zh_cn&edition=full","pubTime":"2025-06-28 09:33","pubTimestamp":1751074413,"startTime":"0","endTime":"0","summary":"美东时间2025年6月27日,Cellectar Biosciences, Inc.成交额为92.11万美元,成交额较昨日减少61.20%,当日成交量为11.86万股。Cellectar Biosciences, Inc.于2025年6月27日涨7.05%,报7.9美元,该股过去5个交易日跌9.82%,年初至今跌11.93%,过去60日跌9.82%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-06-27|92.11万|-61.20%|11.86万|#|2025-06-26|237.40万|2.78%|33.12万|#|2025-06-25|230.98万|42.75%|27.63万|#|2025-06-24|161.80万|141.06%|17.97万|#|2025-06-23|67.12万|-44.63%|229.62万|Cellectar Biosciences Inc 是一家临床阶段的生物制药公司。公司有一个运营和可报告的部门,专注利用PDC平台开发治疗癌症的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250628093334a4c2358e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250628093334a4c2358e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CLRB"],"gpt_icon":0},{"id":"2546275836","title":"Cellectar Biosciences, Inc.6月25日成交额为230.98万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2546275836","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546275836?lang=zh_cn&edition=full","pubTime":"2025-06-26 09:34","pubTimestamp":1750901667,"startTime":"0","endTime":"0","summary":"美东时间2025年6月25日,Cellectar Biosciences, Inc.成交额为230.98万美元,成交额较昨日增加42.75%,当日成交量为27.63万股。Cellectar Biosciences, Inc.于2025年6月25日跌18.14%,报7.94美元,该股过去5个交易日跌24.6%,年初至今跌11.48%,过去60日跌21.0%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-06-25|230.98万|42.75%|27.63万|#|2025-06-24|161.80万|141.06%|17.97万|#|2025-06-23|67.12万|-44.63%|229.62万|#|2025-06-20|121.22万|47.77%|384.31万|#|2025-06-18|82.04万|-7.04%|218.12万|Cellectar Biosciences Inc 是一家临床阶段的生物制药公司。公司有一个运营和可报告的部门,专注利用PDC平台开发治疗癌症的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250626093658a71df196&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250626093658a71df196&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CLRB"],"gpt_icon":0},{"id":"2546268546","title":"Cellectar Biosciences, Inc.6月24日成交额为161.80万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2546268546","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546268546?lang=zh_cn&edition=full","pubTime":"2025-06-25 09:33","pubTimestamp":1750815203,"startTime":"0","endTime":"0","summary":"美东时间2025年6月24日,Cellectar Biosciences, Inc.成交额为161.80万美元,成交额较昨日增加141.06%,当日成交量为17.97万股。Cellectar Biosciences, Inc.于2025年6月24日涨8.57%,报9.7美元,该股过去5个交易日跌15.36%,年初至今涨8.14%,过去60日跌10.19%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-06-24|161.80万|141.06%|17.97万|#|2025-06-23|67.12万|-44.63%|229.62万|#|2025-06-20|121.22万|47.77%|384.31万|#|2025-06-18|82.04万|-7.04%|218.12万|#|2025-06-17|88.25万|15.41%|241.57万|Cellectar Biosciences Inc 是一家临床阶段的生物制药公司。公司有一个运营和可报告的部门,专注利用PDC平台开发治疗癌症的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250625093503a4bc5f3f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250625093503a4bc5f3f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CLRB","BK4139"],"gpt_icon":0},{"id":"2545842212","title":"Cellectar Biosciences, Inc.6月23日成交额为67.12万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2545842212","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545842212?lang=zh_cn&edition=full","pubTime":"2025-06-24 09:33","pubTimestamp":1750728784,"startTime":"0","endTime":"0","summary":"美东时间2025年6月23日,Cellectar Biosciences, Inc.成交额为67.12万美元,成交额较昨日减少44.63%,当日成交量为229.62万股。Cellectar Biosciences, Inc.于2025年6月23日涨2.06%,报0.298美元,该股过去5个交易日跌27.89%,年初至今跌0.4%,过去60日跌18.19%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-06-23|67.12万|-44.63%|229.62万|#|2025-06-20|121.22万|47.77%|384.31万|#|2025-06-18|82.04万|-7.04%|218.12万|#|2025-06-17|88.25万|15.41%|241.57万|#|2025-06-16|76.47万|-36.25%|196.71万|Cellectar Biosciences Inc 是一家临床阶段的生物制药公司。公司有一个运营和可报告的部门,专注利用PDC平台开发治疗癌症的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250624093505a71a47a4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250624093505a71a47a4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CLRB"],"gpt_icon":0},{"id":"2544178681","title":"Cellectar Biosciences, Inc.盘中异动 早盘股价大跌8.89%报0.333美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2544178681","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544178681?lang=zh_cn&edition=full","pubTime":"2025-06-20 21:31","pubTimestamp":1750426288,"startTime":"0","endTime":"0","summary":"北京时间2025年06月20日21时31分,Cellectar Biosciences, Inc.股票出现波动,股价大幅下跌8.89%。截至发稿,该股报0.333美元/股,成交量56.5736万股,换手率1.23%,振幅3.28%。Cellectar Biosciences, Inc.股票所在的生物技术行业中,整体涨幅为0.39%。其相关个股中,Abpro Holdings Inc C/Wts 12/11/2029 、Processa Pharmaceuticals, Inc.、Coeptis Therapeutics Holdings Inc C/Wts 28/10/2027 涨幅较大,Processa Pharmaceuticals, Inc.、Nucana Plc、Aptevo Therapeutics Inc.较为活跃,换手率分别为520.64%、144.27%、119.88%,振幅较大的相关个股有Actuate Therapeutics, Inc.、Fate Therapeutics, Inc.、Xenon制药,振幅分别为108.41%、105.79%、101.91%。Cellectar Biosciences, Inc.公司简介:Cellectar Biosciences Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250620213129a714a4e0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250620213129a714a4e0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CLRB","BK4139"],"gpt_icon":0},{"id":"2544174489","title":"Cellectar Biosciences, Inc.6月17日成交额为88.25万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2544174489","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544174489?lang=zh_cn&edition=full","pubTime":"2025-06-18 09:34","pubTimestamp":1750210460,"startTime":"0","endTime":"0","summary":"美东时间2025年6月17日,Cellectar Biosciences, Inc.成交额为88.25万美元,成交额较昨日增加15.41%,当日成交量为241.57万股。Cellectar Biosciences, Inc.于2025年6月17日跌8.06%,报0.351美元,该股过去5个交易日跌3.99%,年初至今涨17.53%,过去60日跌4.77%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-06-17|88.25万|15.41%|241.57万|#|2025-06-16|76.47万|-36.25%|196.71万|#|2025-06-13|119.94万|-53.82%|284.29万|#|2025-06-12|259.70万|-57.55%|580.82万|#|2025-06-11|611.73万|234.28%|1478.04万|Cellectar Biosciences Inc 是一家临床阶段的生物制药公司。公司有一个运营和可报告的部门,专注利用PDC平台开发治疗癌症的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250618094059a4af7a75&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250618094059a4af7a75&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CLRB","BK4139"],"gpt_icon":0},{"id":"2544980949","title":"Cellectar Biosciences, Inc.6月16日成交额为76.47万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2544980949","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544980949?lang=zh_cn&edition=full","pubTime":"2025-06-17 09:34","pubTimestamp":1750124046,"startTime":"0","endTime":"0","summary":"美东时间2025年6月16日,Cellectar Biosciences, Inc.成交额为76.47万美元,成交额较昨日减少36.25%,当日成交量为196.71万股。Cellectar Biosciences, Inc.于2025年6月16日跌7.5%,报0.382美元,该股过去5个交易日涨7.66%,年初至今涨27.83%,过去60日涨0.58%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-06-16|76.47万|-36.25%|196.71万|#|2025-06-13|119.94万|-53.82%|284.29万|#|2025-06-12|259.70万|-57.55%|580.82万|#|2025-06-11|611.73万|234.28%|1478.04万|#|2025-06-10|183.00万|-25.28%|486.50万|Cellectar Biosciences Inc 是一家临床阶段的生物制药公司。公司有一个运营和可报告的部门,专注利用PDC平台开发治疗癌症的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250617093502a4ad3351&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250617093502a4ad3351&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CLRB","BK4139"],"gpt_icon":0},{"id":"2543633450","title":"Cellectar Biosciences, Inc.盘中异动 早盘快速下挫5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2543633450","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2543633450?lang=zh_cn&edition=full","pubTime":"2025-06-13 22:27","pubTimestamp":1749824844,"startTime":"0","endTime":"0","summary":"北京时间2025年06月13日22时27分,Cellectar Biosciences, Inc.股票出现异动,股价快速跳水5.01%。Cellectar Biosciences, Inc.股票所在的生物技术行业中,整体跌幅为0.49%。其相关个股中,Jasper Therapeutics Inc C/Wts 24/09/2026 、塞德斯医疗、Sol-Gel Technologies Ltd.涨幅较大,Nucana Plc、Alzamend Neuro, Inc.、Eyenovia, Inc.较为活跃,换手率分别为650.43%、66.60%、29.24%,振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Klotho Neurosciences Inc C/Wts 21/06/2029 、Carisma Therapeutics, Inc.,振幅分别为46.36%、35.79%、31.59%。Cellectar Biosciences, Inc.公司简介:Cellectar Biosciences Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250613222724977e571e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250613222724977e571e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CLRB"],"gpt_icon":0},{"id":"2542554045","title":"Cellectar Biosciences, Inc.6月11日成交额为611.73万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2542554045","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542554045?lang=zh_cn&edition=full","pubTime":"2025-06-12 09:34","pubTimestamp":1749692065,"startTime":"0","endTime":"0","summary":"美东时间2025年6月11日,Cellectar Biosciences, Inc.成交额为611.73万美元,成交额较昨日增加234.28%,当日成交量为1478.04万股。Cellectar Biosciences, Inc.于2025年6月11日涨16.64%,报0.427美元,该股过去5个交易日跌7.62%,年初至今涨42.74%,过去60日涨26.65%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-06-11|611.73万|234.28%|1478.04万|#|2025-06-10|183.00万|-25.28%|486.50万|#|2025-06-09|244.91万|-26.78%|696.18万|#|2025-06-06|334.48万|-79.18%|897.78万|#|2025-06-05|1606.51万|-95.25%|4000.94万|Cellectar Biosciences Inc 是一家临床阶段的生物制药公司。公司有一个运营和可报告的部门,专注利用PDC平台开发治疗癌症的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250612093619a4a43470&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250612093619a4a43470&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CLRB"],"gpt_icon":0},{"id":"2542348401","title":"Cellectar Biosciences, Inc.盘中异动 早盘股价大涨5.18%报0.373美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2542348401","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542348401?lang=zh_cn&edition=full","pubTime":"2025-06-10 22:19","pubTimestamp":1749565160,"startTime":"0","endTime":"0","summary":"北京时间2025年06月10日22时19分,Cellectar Biosciences, Inc.股票出现异动,股价急速上涨5.18%。截至发稿,该股报0.373美元/股,成交量128.713万股,换手率2.79%,振幅5.83%。Cellectar Biosciences, Inc.股票所在的生物技术行业中,整体涨幅为0.63%。其相关个股中,Carisma Therapeutics, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Nucana Plc涨幅较大,Nucana Plc、Windtree Therapeutics, Inc.、Evogene Ltd.较为活跃,换手率分别为19080.43%、2208.22%、1080.98%,振幅较大的相关个股有Klotho Neurosciences Inc C/Wts 21/06/2029 、Carisma Therapeutics, Inc.、Nucana Plc,振幅分别为253.85%、191.40%、99.74%。Cellectar Biosciences, Inc.公司简介:Cellectar Biosciences Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250610221920a4a21371&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250610221920a4a21371&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CLRB"],"gpt_icon":0},{"id":"2542338657","title":"Cellectar Biosciences, Inc.盘中异动 早盘大幅下跌5.18%报0.342美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2542338657","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542338657?lang=zh_cn&edition=full","pubTime":"2025-06-09 21:51","pubTimestamp":1749477099,"startTime":"0","endTime":"0","summary":"北京时间2025年06月09日21时51分,Cellectar Biosciences, Inc.股票出现异动,股价急速下跌5.18%。截至发稿,该股报0.342美元/股,成交量168.52万股,换手率3.66%,振幅2.74%。Cellectar Biosciences, Inc.股票所在的生物技术行业中,整体涨幅为0.53%。其相关个股中,Klotho Neurosciences, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Citius Pharmaceuticals, Inc.涨幅较大,Pmgc Holdings Inc.、Klotho Neurosciences, Inc.、Synaptogenix, Inc.较为活跃,换手率分别为1452.60%、1187.87%、860.43%,振幅较大的相关个股有Klotho Neurosciences, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Citius Pharmaceuticals, Inc.,振幅分别为100.00%、93.26%、51.70%。Cellectar Biosciences, Inc.公司简介:Cellectar Biosciences Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506092151399514d9ab&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506092151399514d9ab&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CLRB","BK4139"],"gpt_icon":0},{"id":"2541892116","title":"Cellectar Biosciences, Inc.6月6日成交额为334.48万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2541892116","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2541892116?lang=zh_cn&edition=full","pubTime":"2025-06-07 09:29","pubTimestamp":1749259779,"startTime":"0","endTime":"0","summary":"美东时间2025年6月6日,Cellectar Biosciences, Inc.成交额为334.48万美元,成交额较昨日减少79.18%,当日成交量为897.78万股。Cellectar Biosciences, Inc.于2025年6月6日跌11.59%,报0.361美元,该股过去5个交易日涨41.49%,年初至今涨20.67%,过去60日涨13.82%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-06-06|334.48万|-79.18%|897.78万|#|2025-06-05|1606.51万|-95.25%|4000.94万|#|2025-06-04|3.38亿|107081.82%|6.26亿|#|2025-06-03|31.53万|72.56%|114.53万|#|2025-06-02|18.27万|232.31%|70.56万|Cellectar Biosciences Inc 是一家临床阶段的生物制药公司。公司有一个运营和可报告的部门,专注利用PDC平台开发治疗癌症的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250607092945a6fdcb95&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250607092945a6fdcb95&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CLRB","BK4139"],"gpt_icon":0},{"id":"2541888107","title":"Cellectar Biosciences, Inc.6月5日成交额为1606.51万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2541888107","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2541888107?lang=zh_cn&edition=full","pubTime":"2025-06-06 09:28","pubTimestamp":1749173339,"startTime":"0","endTime":"0","summary":"美东时间2025年6月5日,Cellectar Biosciences, Inc.成交额为1606.51万美元,成交额较昨日减少95.25%,当日成交量为4000.94万股。Cellectar Biosciences, Inc.于2025年6月5日跌11.61%,报0.408美元,该股过去5个交易日涨54.58%,年初至今涨36.49%,过去60日涨30.38%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-06-05|1606.51万|-95.25%|4000.94万|#|2025-06-04|3.38亿|107081.82%|6.26亿|#|2025-06-03|31.53万|72.56%|114.53万|#|2025-06-02|18.27万|232.31%|70.56万|#|2025-05-30|5.50万|-81.09%|21.39万|Cellectar Biosciences Inc 是一家临床阶段的生物制药公司。公司有一个运营和可报告的部门,专注利用PDC平台开发治疗癌症的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250606092909a49c29bc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250606092909a49c29bc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CLRB"],"gpt_icon":0},{"id":"2541016705","title":"Cellectar Biosciences, Inc.6月4日成交额为3.38亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2541016705","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2541016705?lang=zh_cn&edition=full","pubTime":"2025-06-05 09:28","pubTimestamp":1749086926,"startTime":"0","endTime":"0","summary":"美东时间2025年6月4日,Cellectar Biosciences, Inc.成交额为3.38亿美元,成交额较昨日增加107081.82%,当日成交量为6.26亿股。Cellectar Biosciences, Inc.于2025年6月4日涨66.32%,报0.462美元,该股过去5个交易日涨87.68%,年初至今涨54.41%,过去60日涨46.57%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-06-04|3.38亿|107081.82%|6.26亿|#|2025-06-03|31.53万|72.56%|114.53万|#|2025-06-02|18.27万|232.31%|70.56万|#|2025-05-30|5.50万|-81.09%|21.39万|#|2025-05-29|29.08万|69.00%|112.89万|Cellectar Biosciences Inc 是一家临床阶段的生物制药公司。公司有一个运营和可报告的部门,专注利用PDC平台开发治疗癌症的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250605092859a6faf6ff&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250605092859a6faf6ff&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CLRB","BK4139"],"gpt_icon":0},{"id":"2540703855","title":"Cellectar Biosciences, Inc.盘中异动 股价大涨5.65%报0.277美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2540703855","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2540703855?lang=zh_cn&edition=full","pubTime":"2025-06-03 23:13","pubTimestamp":1748963630,"startTime":"0","endTime":"0","summary":"北京时间2025年06月03日23时13分,Cellectar Biosciences, Inc.股票出现波动,股价大幅上涨5.65%。截至发稿,该股报0.277美元/股,成交量38.9368万股,换手率0.84%,振幅5.27%。Cellectar Biosciences, Inc.股票所在的生物技术行业中,整体涨幅为0.74%。其相关个股中,Biomea Fusion, Inc.、Traws Pharma, Inc.、天境生物涨幅较大,Revelation Biosciences, Inc.、Traws Pharma, Inc.、Nucana Plc较为活跃,换手率分别为3913.24%、1013.22%、908.75%,振幅较大的相关个股有Nls Pharmaceutics Ltd C/Wts 02/02/2026、Biomea Fusion, Inc.、Renovaro Inc.,振幅分别为79.71%、69.03%、57.30%。Cellectar Biosciences, Inc.公司简介:Cellectar Biosciences Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250603231350950d19c9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250603231350950d19c9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CLRB","BK4139"],"gpt_icon":0},{"id":"2539271875","title":"Cellectar Biosciences, Inc.盘中异动 股价大跌6.02%报0.248美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2539271875","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2539271875?lang=zh_cn&edition=full","pubTime":"2025-05-31 00:34","pubTimestamp":1748622864,"startTime":"0","endTime":"0","summary":"北京时间2025年05月31日00时34分,Cellectar Biosciences, Inc.股票出现异动,股价急速下挫6.02%。截至发稿,该股报0.248美元/股,成交量14.5683万股,换手率0.32%,振幅5.08%。Cellectar Biosciences, Inc.股票所在的生物技术行业中,整体跌幅为4.35%。其相关个股中,Bioline Rx Ltd、Imunon, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 涨幅较大,Bioline Rx Ltd、Nucana Plc、Alzamend Neuro, Inc.较为活跃,换手率分别为878.00%、323.33%、152.94%,振幅较大的相关个股有Nls Pharmaceutics Ltd C/Wts 02/02/2026、Psyence Biomedical Ltd C/Wts 25/01/2029、Bioline Rx Ltd,振幅分别为112.81%、70.48%、66.47%。Cellectar Biosciences, Inc.公司简介:Cellectar Biosciences Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250531003424a4931a95&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250531003424a4931a95&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CLRB","BK4139"],"gpt_icon":0},{"id":"2537930383","title":"Cellectar Biosciences, Inc.盘中异动 股价大跌5.11%报0.251美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2537930383","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537930383?lang=zh_cn&edition=full","pubTime":"2025-05-22 00:23","pubTimestamp":1747844583,"startTime":"0","endTime":"0","summary":"北京时间2025年05月22日00时23分,Cellectar Biosciences, Inc.股票出现波动,股价急速下挫5.11%。截至发稿,该股报0.251美元/股,成交量30.9751万股,换手率0.67%,振幅8.64%。Cellectar Biosciences, Inc.股票所在的生物技术行业中,整体跌幅为0.38%。Cellectar Biosciences, Inc.公司简介:Cellectar Biosciences Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250522002304a4870b55&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250522002304a4870b55&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CLRB"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cellectar.com","stockEarnings":[{"period":"1week","weight":0.0254},{"period":"1month","weight":-0.5446},{"period":"3month","weight":-0.4074},{"period":"6month","weight":-0.4273},{"period":"1year","weight":-0.9329},{"period":"ytd","weight":-0.4593}],"compareEarnings":[{"period":"1week","weight":0.0058},{"period":"1month","weight":0.0407},{"period":"3month","weight":0.1896},{"period":"6month","weight":0.0751},{"period":"1year","weight":0.1228},{"period":"ytd","weight":0.0648}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Cellectar Biosciences, Inc.以前名为Novelos Therapeutics, Inc.于1996年6月成立于特拉华州。2014年2月11日,公司更名为现在的名字。该公司是一家后期临床生物制药公司,专注于癌症治疗药物的发现、开发和商业化。该公司的核心目标是利用专有的磷脂醚药物偶联物递送平台开发PDC,这些PDC旨在专门针对癌细胞,并由于更少的脱靶效应而提供更好的功效和更好的安全性。","yearOnYearQuotes":[{"month":1,"riseRate":0.363636,"avgChangeRate":0.010906},{"month":2,"riseRate":0.636364,"avgChangeRate":0.025528},{"month":3,"riseRate":0.545455,"avgChangeRate":-0.01778},{"month":4,"riseRate":0.181818,"avgChangeRate":-0.105027},{"month":5,"riseRate":0.363636,"avgChangeRate":0.04422},{"month":6,"riseRate":0.363636,"avgChangeRate":-0.071723},{"month":7,"riseRate":0.272727,"avgChangeRate":-0.09617},{"month":8,"riseRate":0.4,"avgChangeRate":-0.015388},{"month":9,"riseRate":0.363636,"avgChangeRate":-0.040633},{"month":10,"riseRate":0.090909,"avgChangeRate":-0.138405},{"month":11,"riseRate":0.363636,"avgChangeRate":-0.073945},{"month":12,"riseRate":0.363636,"avgChangeRate":-0.052459}],"exchange":"NASDAQ","name":"Cellectar Biosciences Inc.","nameEN":"Cellectar Biosciences"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.3","shortVersion":"4.34.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Cellectar Biosciences Inc.(CLRB)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Cellectar Biosciences Inc.(CLRB)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Cellectar Biosciences Inc.,CLRB,Cellectar Biosciences Inc.股票,Cellectar Biosciences Inc.股票老虎,Cellectar Biosciences Inc.股票老虎国际,Cellectar Biosciences Inc.行情,Cellectar Biosciences Inc.股票行情,Cellectar Biosciences Inc.股价,Cellectar Biosciences Inc.股市,Cellectar Biosciences Inc.股票价格,Cellectar Biosciences Inc.股票交易,Cellectar Biosciences Inc.股票购买,Cellectar Biosciences Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Cellectar Biosciences Inc.(CLRB)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Cellectar Biosciences Inc.(CLRB)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}